Cargando…
d-Dimer elevation and adverse outcomes
d-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevate...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300425/ https://www.ncbi.nlm.nih.gov/pubmed/25006010 http://dx.doi.org/10.1007/s11239-014-1101-6 |
_version_ | 1782353520673947648 |
---|---|
author | Halaby, Rim Popma, Christopher J. Cohen, Ander Chi, Gerald Zacarkim, Marcelo Rodrigues Romero, Gonzalo Goldhaber, Samuel Z. Hull, Russell Hernandez, Adrian Mentz, Robert Harrington, Robert Lip, Gregory Peacock, Frank Welker, James Martin-Loeches, Ignacio Daaboul, Yazan Korjian, Serge Gibson, C. Michael |
author_facet | Halaby, Rim Popma, Christopher J. Cohen, Ander Chi, Gerald Zacarkim, Marcelo Rodrigues Romero, Gonzalo Goldhaber, Samuel Z. Hull, Russell Hernandez, Adrian Mentz, Robert Harrington, Robert Lip, Gregory Peacock, Frank Welker, James Martin-Loeches, Ignacio Daaboul, Yazan Korjian, Serge Gibson, C. Michael |
author_sort | Halaby, Rim |
collection | PubMed |
description | d-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated d-dimer with adverse outcomes has received far less emphasis. An elevated d-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated d-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the d-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted. |
format | Online Article Text |
id | pubmed-4300425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-43004252015-01-23 d-Dimer elevation and adverse outcomes Halaby, Rim Popma, Christopher J. Cohen, Ander Chi, Gerald Zacarkim, Marcelo Rodrigues Romero, Gonzalo Goldhaber, Samuel Z. Hull, Russell Hernandez, Adrian Mentz, Robert Harrington, Robert Lip, Gregory Peacock, Frank Welker, James Martin-Loeches, Ignacio Daaboul, Yazan Korjian, Serge Gibson, C. Michael J Thromb Thrombolysis Article d-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated d-dimer with adverse outcomes has received far less emphasis. An elevated d-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated d-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the d-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted. Springer US 2014-07-09 2015 /pmc/articles/PMC4300425/ /pubmed/25006010 http://dx.doi.org/10.1007/s11239-014-1101-6 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Article Halaby, Rim Popma, Christopher J. Cohen, Ander Chi, Gerald Zacarkim, Marcelo Rodrigues Romero, Gonzalo Goldhaber, Samuel Z. Hull, Russell Hernandez, Adrian Mentz, Robert Harrington, Robert Lip, Gregory Peacock, Frank Welker, James Martin-Loeches, Ignacio Daaboul, Yazan Korjian, Serge Gibson, C. Michael d-Dimer elevation and adverse outcomes |
title | d-Dimer elevation and adverse outcomes |
title_full | d-Dimer elevation and adverse outcomes |
title_fullStr | d-Dimer elevation and adverse outcomes |
title_full_unstemmed | d-Dimer elevation and adverse outcomes |
title_short | d-Dimer elevation and adverse outcomes |
title_sort | d-dimer elevation and adverse outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300425/ https://www.ncbi.nlm.nih.gov/pubmed/25006010 http://dx.doi.org/10.1007/s11239-014-1101-6 |
work_keys_str_mv | AT halabyrim ddimerelevationandadverseoutcomes AT popmachristopherj ddimerelevationandadverseoutcomes AT cohenander ddimerelevationandadverseoutcomes AT chigerald ddimerelevationandadverseoutcomes AT zacarkimmarcelorodrigues ddimerelevationandadverseoutcomes AT romerogonzalo ddimerelevationandadverseoutcomes AT goldhabersamuelz ddimerelevationandadverseoutcomes AT hullrussell ddimerelevationandadverseoutcomes AT hernandezadrian ddimerelevationandadverseoutcomes AT mentzrobert ddimerelevationandadverseoutcomes AT harringtonrobert ddimerelevationandadverseoutcomes AT lipgregory ddimerelevationandadverseoutcomes AT peacockfrank ddimerelevationandadverseoutcomes AT welkerjames ddimerelevationandadverseoutcomes AT martinloechesignacio ddimerelevationandadverseoutcomes AT daaboulyazan ddimerelevationandadverseoutcomes AT korjianserge ddimerelevationandadverseoutcomes AT gibsoncmichael ddimerelevationandadverseoutcomes |